Hutch News Stories | July 15, 2022
Hutch scientists aim high by way of the lowly microorganisms that call us home
MicrobiomePost | June 13, 2022
A study from Dr. Kate Markey suggests a link between microbiota, microbial metabolites and the maintenance of specific immune cells.
The Hematologist | June 20, 2022
Adding microbiota profiling as a routine correlate in clinical and preclinical studies is likely to improve our understanding of the determinants of immune function. This, in turn, may offer insight into optimal strategies to manipulate the microbiome to ensure the best possible patient outcomes for immune-mediated conditions and complications of care.
Science Translational Medicine | May 25, 2022
Dr. Kate Markey's recently published study reports that a diverse microbiome is key for supporting unconventional T cells (MAITS, V-delta-2s) after allo-HCT, which in turn = better HCT outcomes.